Stockreport

J&J files U.S. applications for expanded use of IV golimumab [Seeking Alpha]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF Johnson & Johnson (NYSE:JNJfiledSimponi Aria is an intravenously administered formulation of Simponi (administered via subcutaneous injection). [Read more]